Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAPORISE: Tobramycin Inhalation for VAP
NCT02440828Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Mar 2015
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of tobramycin in ventilator-associated pneumonia (VAP), sponsored by Erasmus MC. Started Mar 2015; status: completed.
02
Drugs
tobramycin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT02440828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02440828.